This page lists the SEC filings reported by Quogue Capital LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-03-19 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 30,000,000 | 11.6% | EDGAR |
| SC 13D/A | 2023-10-27 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 25,000,000 | 15.8% | EDGAR |
| SC 13D/A | 2023-01-13 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 20,000,000 | 12.5% | EDGAR |
| SC 13D/A | 2018-12-07 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 9,000,000 | 7.2% | EDGAR |
| SC 13D | 2016-06-13 | Quogue Capital LLC | Lion Biotechnologies, Inc. | 5,778,947 | 9.6% | EDGAR |
| SC 13G/A | 2013-06-27 | Quogue Capital LLC | INFINITY PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | Quogue Capital LLC | PALATIN TECHNOLOGIES INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | Quogue Capital LLC | INFINITY PHARMACEUTICALS, INC. | 2,905,214 | 6.4% | EDGAR |
| SC 13G/A | 2013-02-07 | Quogue Capital LLC | REPROS THERAPEUTICS INC. | 0 | 0.0% | EDGAR |
| SC 13G | 2012-03-30 | Quogue Capital LLC | INFINITY PHARMACEUTICALS, INC. | 2,150,000 | 8.0% | EDGAR |
| SC 13G | 2011-02-28 | Quogue Capital LLC | PALATIN TECHNOLOGIES INC | 3,646,391 | 9.9% | EDGAR |
| SC 13G/A | 2011-02-14 | Quogue Capital LLC | REPROS THERAPEUTICS INC. | 1,166,180 | 9.9% | EDGAR |
| SC 13G/A | 2011-02-14 | Quogue Capital LLC | Talon Therapeutics, Inc. | 876,206 | 3.9% | EDGAR |
| SC 13G/A | 2011-02-14 | Quogue Capital LLC | PHARMACYCLICS INC | 1,500,000 | 2.5% | EDGAR |
| SC 13G/A | 2011-02-14 | Quogue Capital LLC | Endo Pharmaceuticals Solutions Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2010-09-01 | Quogue Capital LLC | PHARMACYCLICS INC | 3,330,000 | 5.6% | EDGAR |
| SC 13G/A | 2010-02-12 | Quogue Capital LLC | Hana Biosciences Inc | 7,612,000 | 10.0% | EDGAR |
| SC 13G | 2009-10-20 | Quogue Capital LLC | Hana Biosciences Inc | 7,612,000 | 10.0% | EDGAR |
| SC 13G/A | 2009-02-27 | Quogue Capital LLC | PENWEST PHARMACEUTICALS CO | 0 | 0.0% | EDGAR |
| SC 13G | 2009-01-15 | Quogue Capital LLC | INDEVUS PHARMACEUTICALS INC | 5,595,408 | 7.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.